A new type of solar technology has seemed promising in recent years. Halide perovskite solar cells are both high-performing and low-cost for producing electrical energy - two necessary ingredients for any successful solar technology of the future. But new solar cell materials should also mat
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif
An Emory University study discovered that extracts from two common wild plants decrease the capacity of the virus that causes Covid-19 to infect live cells.
The host cell's molecular arsenal is used by viruses to multiply. This is something that researchers from the University of Bonn's Cluster of Excellence ImmunoSensation2 and their Japanese counterparts hope to take advantage of for the treatment of influenza.
Most proteins localize to distinct protein-rich droplets in cells, also known as "cellular condensates". Such proteins contain sequence features that function as address labels, telling the protein which condensate to move into. When the labels get screwed up, proteins may end up in the wron
The disulfidptosis form of cell death, which was previously unknown, is described in a study from the University of Texas MD Anderson Cancer Center that was published today in Nature Cell Biology. This finding may pave the way for fresh cancer treatment options.
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.
A recent study from Cornell University offers a new perspective on how the chemotherapy drug etoposide delays and kills vital enzymes that support the growth of cancer cells.
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.